Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Long-term mortality in anorexia nervosa: a report after an 8-year follow-up and a review of the most recent literature.

Signorini A, De Filippo E, Panico S, De Caprio C, Pasanisi F, Contaldo F.

Eur J Clin Nutr. 2007 Jan;61(1):119-22. Epub 2006 Aug 2. Review.

PMID:
16885933
2.

The effect of including C-reactive protein in cardiovascular risk prediction models for women.

Cook NR, Buring JE, Ridker PM.

Ann Intern Med. 2006 Jul 4;145(1):21-9.

PMID:
16818925
3.

Etiology of hypercholesterolemia in patients with anorexia nervosa.

Ohwada R, Hotta M, Oikawa S, Takano K.

Int J Eat Disord. 2006 Nov;39(7):598-601.

PMID:
16791856
4.

Cholesterol concentrations in patients with Anorexia Nervosa and in healthy controls.

Matzkin VB, Geissler C, Coniglio R, Selles J, Bello M.

Int J Psychiatr Nurs Res. 2006 Jan;11(2):1283-93.

PMID:
16459892
5.

Progestins affect mechanism of estrogen-induced C-reactive protein stimulation.

Reuben DB, Palla SL, Hu P, Reboussin BA, Crandall C, Herrington DM, Barrett-Connor E, Greendale GA.

Am J Med. 2006 Feb;119(2):167.e1-8.

PMID:
16443423
7.

Distribution and determinants of serum high-sensitive C-reactive protein in a population of young adults: The Cardiovascular Risk in Young Finns Study.

Raitakari M, Mansikkaniemi K, Marniemi J, Viikari JS, Raitakari OT.

J Intern Med. 2005 Nov;258(5):428-34.

8.

The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.

Eilertsen AL, Høibraaten E, Os I, Andersen TO, Sandvik L, Sandset PM.

Maturitas. 2005 Oct 16;52(2):111-8.

PMID:
16186073
9.

Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy.

Vitale C, Cornoldi A, Gebara O, Silvestri A, Wajngarten M, Cerquetani E, Fini M, Ramires JA, Rosano GM.

Menopause. 2005 Sep-Oct;12(5):552-8. Epub 2005 Sep 1.

PMID:
16145309
10.

The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial.

Hu P, Greendale GA, Palla SL, Reboussin BA, Herrington DM, Barrett-Connor E, Reuben DB.

Atherosclerosis. 2006 Apr;185(2):347-52. Epub 2005 Jul 14.

PMID:
16023653
11.

Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis.

Baillargeon JP, McClish DK, Essah PA, Nestler JE.

J Clin Endocrinol Metab. 2005 Jul;90(7):3863-70. Epub 2005 Apr 6.

PMID:
15814774
12.

Medical findings in outpatients with anorexia nervosa.

Miller KK, Grinspoon SK, Ciampa J, Hier J, Herzog D, Klibanski A.

Arch Intern Med. 2005 Mar 14;165(5):561-6.

PMID:
15767533
13.

Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women.

Rossi R, Bursi F, Veronesi B, Cagnacci A, Modena MG.

Maturitas. 2004 Dec 10;49(4):315-20.

PMID:
15531127
14.

Estrogen regulation of growth hormone action.

Leung KC, Johannsson G, Leong GM, Ho KK.

Endocr Rev. 2004 Oct;25(5):693-721. Review.

PMID:
15466938
15.

Preservation of neuroendocrine control of reproductive function despite severe undernutrition.

Miller KK, Grinspoon S, Gleysteen S, Grieco KA, Ciampa J, Breu J, Herzog DB, Klibanski A.

J Clin Endocrinol Metab. 2004 Sep;89(9):4434-8.

PMID:
15356043
16.

Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults.

Williams MJ, Williams SM, Milne BJ, Hancox RJ, Poulton R.

Int J Obes Relat Metab Disord. 2004 Aug;28(8):998-1003.

PMID:
15211365
17.

Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholesterolaemia.

Weinbrenner T, Züger M, Jacoby GE, Herpertz S, Liedtke R, Sudhop T, Gouni-Berthold I, Axelson M, Berthold HK.

Br J Nutr. 2004 Jun;91(6):959-69.

PMID:
15182399
18.

Effects of oestrogen replacement therapy on serum C-reactive protein levels in hysterectomised women.

Kiran H, Kiran G, Ekerbicer HC, Guven AM, Kilinc M.

Aust N Z J Obstet Gynaecol. 2004 Apr;44(2):131-4.

PMID:
15089836
19.

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S; Women's Health Initiative Steering Committee.

JAMA. 2004 Apr 14;291(14):1701-12.

PMID:
15082697
20.

C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups.

Heald AH, Anderson SG, Ivison F, Laing I, Gibson JM, Cruickshank K.

Atherosclerosis. 2003 Sep;170(1):79-86.

PMID:
12957685

Supplemental Content

Support Center